Skip to main content

Branded

  • Upsher-Smith Laboratories gains approval for testosterone gel Vogelxo

    MAPLE GROVE, Minn. - Upsher-Smith Laboratories on Wednesday announced that it has received final approval from the Food and Drug Administration for its new drug application for Vogelxo (testosterone) gel for topical use CIII.  

    Vogelxo is a Schedule CIII androgen indicated for testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired).

  • CDC updates polio vaccine recommendations

    ATLANTA - The Centers for Disease Control and Prevention recently updated a health advisory, recommending an inactivated poliovirus booster for adults traveling to countries with an active wild polio virus in circulation. 

    These countries include Cameroon, Pakistan and the Syrian Arab Republic. The United States is not expected to issue any requirements for entry into the United States, however, according to the CDC.

  • HMN expands Cardiology Network through agreement with American College of Cardiology

    DARIEN, Conn. — Health Media Network and the American College of Cardiology on Wednesday announced a strategic partnership that will significantly increase the size of HMN's Cardiology Network while broadening the distribution of ACC's CardioSmart Initiative. CardioSmart provides tools and resources to heart health providers and the populations they serve to enhance the dialogue between all the members of the care team and improve health outcomes. 

  • Cardinal Health launches new MTM solution

    DUBLIN, Ohio — Cardinal Health on Wednesday launched a new solution to make it easier and more time-efficient for retail pharmacies to help patients better understand and adhere to their medications.

  • Cases of whooping cough on the rise in California

    SACRAMENTO, Calif. - Ron Chapman, director of the California Department of Public Health and state health officer, last week warned that the number of pertussis (whooping cough) cases continue to increase in California.

    CDPH has received reports of 2,649 cases of pertussis occurring from January through May 27, 2014, more than the number of cases reported in all of 2013. More than 800 cases were reported in April alone, the highest monthly count since the 2010 epidemic.

  • NAPW names Dawn Jackman as the 2014 Professional Woman of the Year

    GARDEN CITY, N.Y. – The National Association of Professional Women on Tuesday honored Dawn Jackman as the 2014 Professional Woman of the Year.

    The National Association of Professional Women is a networking community with more than 600,000 members and nearly 400 Local Chapters.

    “I am constantly conveying what is allowable and isn’t allowable as per the regulations and risks involved with these decisions,” Jackman said, speaking to her responsibilities as associate director, regulatory affairs at Bayer Healthcare.

  • Sandoz obtains rights to Upsher-Smith's branded potassium chloride line of products, Klor-Con

    PRINCETON, N.J. – Sandoz on Tuesday announced an agreement with Upsher-Smith to obtain exclusive U.S. distribution rights for its branded potassium chloride line of products, Klor-Con, and market them under the Sandoz name.

  • Asana BioSciences acquires drug discovery platform from Endo Pharmaceuticals

    BRIDGEWATER, N.J. — Asana BioSciences, a research and development company specializing in the discovery and development of new chemical and biological entities, on Tuesday announced that it has acquired an early stage branded pharmaceutical discovery platform from Endo Pharmaceuticals. Asana's portfolio is comprised of multiple compounds for oncology and pain indications that are ready to enter clinical trials, the company said.

X
This ad will auto-close in 10 seconds